News & Events
Treatment Rapidly Reverses the Effect of Blood Thinner Dabigatran
A new treatment rapidly removes the oral blood thinner dabigatran (PRADAXA®) from circulation within minutes, allowing life-saving clots to form normally.
Official Combination of Philadelphia University & Thomas Jefferson University Signals Disruption in a Stagnant Education Industry
Philadelphia University and Thomas Jefferson University announced their official combination, effective July 1, 2017, creating a comprehensive university designed to deliver high-impact education and value for students in medicine, science, architecture, design, fashion, textiles, health, business, engineering and more.
Dr. Stephen Klasko Ranks Among Top 50 Physician Executives & Leaders by Modern Healthcare
Dr. Stephen Klasko has been recognized by Modern Healthcare - the leader in healthcare business news, research and data - as one of this year’s 50 Most Influential Physician Executives and Leaders.
Molecule May Help Maintain Brain’s Synaptic Balance
Many neurological diseases are malfunctions of synapses, or the points of contact between neurons that allow senses and other information to pass from finger to brain. When the excitatory and inhibitory balance is off, the brain becomes unable to process information normally, leading to conditions like epilepsy. Now researchers at Jefferson have discovered a molecule that may play a role in helping maintain the balance of excitatory and inhibitory neurons.
Infection with Seasonal Flu May Increase Risk of Developing Parkinson's Disease
New research reported suggests that a certain strain of influenza virus predisposes mice to developing pathologies that mimic those seen in Parkinson's disease.
Jefferson Signs Partnership Agreement with Catholic University and Gemelli University Hospital in Italy
Thomas Jefferson University has signed a new partnership with Catholic University of Sacro Cuore and the Gemelli University Hospital in Rome that will allow exchanges of medical students and health research.
Jefferson Researcher Identifies Targets for Better Anti-Thrombotic Medicine
Blood thinners, such as aspirin, reduce the risk of thrombus formation but also interfere with the initial clot formation that is essential for preventing blood loss from the wounds. Now researchers have discovered that a molecule plays a role in thrombus development, but not the initial clot formation, suggesting a new avenue for developing more specific and protective blood thinners.
Sidney Kimmel Cancer Center and Jefferson Health Launch the Neu Center for Supportive Medicine and Cancer Survivorship
The Sidney Kimmel Cancer Center at Jefferson received a $3 million development donation from education and healthcare philanthropists Esperanza and David Neu to establish the Neu Center for Supportive Medicine and Cancer Survivorship.
Sacrificing Sleep for Love
In research published on May 16th in eLife, researchers report discovery of neurons that allow male fruit flies to suppress sleep so they can court female flies.
Buprenorphine Cuts Length of Stay Nearly in Half for Infants Withdrawing from Opioids
Jefferson research shows buprenorphine effectively cuts the length of hospital stay to nearly half in infants withdrawing from opioids.